吴说获悉，Coinbase 创始人 Brian Armstrong 联合创立的长寿科技初创公司 NewLimit 官方宣布完成 4.35 亿美元 C 轮融资，由 Founders Fund 领投，Thrive Capital、Greenoaks、Quiet Capital 等新投资方参投，Kleiner Perkins、Eli Lilly Ventures 等股东继续参与。NewLimit 表示，将把首个衰老重编程药物推进人体临床试验，计划明年启动首个人体试验。 https://t.co/8t6grk99Yp

吴说获悉，Coinbase 创始人 Brian Armstrong 联合创立的长寿科技初创公司 NewLimit 官方宣布完成 4.35 亿美元 C 轮融资，由 Founders Fund 领投，Thrive Capital、Greenoaks、Quiet Capital 等新投资方参投，Kleiner Perkins、Eli Lilly Ventures 等股东继续参与。NewLimit 表示，将把首个衰老重编程药物推进人体临床试验，计划明年启动首个人体试验。 https://t.co/8t6grk99Yp

Coinbase Co-Founder Brian Armstrong;s Longevity Startup NewLimit Raises $435M Series C NewLimit, a longevity biotech startup co-founded by Coinbase CEO Brian Armstrong, announced a $435 million Series C round led by Founders Fund. New investors including Thrive Capital, Greenoaks and Quiet Capital

Exclusive: A longevity biotech co-founded by Coinbase’s CEO more than tripled in value to $3.1 billion—before its drugs begin human testing. https://t.co/X3nCpPfDDw

Exclusive: A longevity biotech co-founded by Coinbase’s CEO more than tripled in value to $3.1 billion—before its drugs begin human testing. https://on.wsj.com/4ufTaaB

Brian Armstrong Backed Startup Raises $435M NewLimit, the longevity biotech startup co founded by Coinbase CEO Brian Armstrong (@brian_armstrong), has secured $435 million in a Series C funding round. The round was led by Founders Fund, with participation from Thrive Capital, Greenoaks, and Quiet